Enhanced bioavailability of oral paclitaxel by valspodar (PSC 833), an inhibitor of small bowel P-glycoprotein and cytochrome P450. Sikic, B. I., Advani, R., Fisher, G. A., Halsey, J., Cohen, P., Lum, B. L. AMER ASSOC CANCER RESEARCH. 2000: 4580S

View details for Web of Science ID 000165409000528